New treatment options for nonsurgical management of uterine fibroids

Новые варианты лечения миомы матки без хирургического вмешательства
Elizabeth A. Stewart, Si Won Lee
2023-05-03

gonadotropin-releasing hormone antagonistsmagnetic resonance-guided focused ultrasound surgerynonsurgical managementuterine artery embolizationuterine fibroids
PURPOSE OF REVIEW: Uterine fibroids is a common problem in reproductive-age individuals, frequently causing abnormal uterine bleeding, bulk symptoms, and adverse reproductive outcomes. Traditionally, almost half of the women with symptomatic fibroids received surgery for definitive treatment. There are a growing number of nonsurgical options for treatment that have become available for patients who desire conservative treatment or those with contraindications to surgery. RECENT FINDINGS: The introduction of oral gonadotropin-releasing hormone antagonists in combination with low-dose physiologic hormonal therapy demonstrated improvement in heavy menstrual bleeding, pain, and quality of life with preservation of bone density and a modest reduction in uterine volume with few hypogonadal side effects. Magnetic resonance-guided focused ultrasound surgery and uterine artery embolization continue to be minimally invasive procedural alternatives to hysterectomy that are safe and effective. SUMMARY: As more options for conservative management of uterine fibroids became available, it is important to counsel patients on possible options based on the size, location, and number of the fibroids as well as severity of the symptoms, plans for pregnancy, how close they are to menopause and their treatment goals.
1
Growing conservative treatment options may benefit patients seeking to avoid surgery or those with contraindications to surgical management.
2
Magnetic resonance-guided focused ultrasound surgery and uterine artery embolization remain safe and effective minimally invasive alternatives to hysterectomy.
3
Nonsurgical treatment selection should consider fibroid size, location, number, symptom severity, pregnancy plans, proximity to menopause, and patient goals.
4
Oral gonadotropin-releasing hormone antagonists combined with low-dose physiologic hormonal therapy improve heavy menstrual bleeding, pain, and quality of life.
5
This combination preserves bone density, modestly reduces uterine volume, and causes few hypogonadal side effects.

uterine fibroids in reproductive-age individuals

nonsurgical conservative treatment options and their effects on bleeding, pain, quality of life, uterine volume, bone density, and reproductive outcomes

Publication Details
Publication Date
2023-05-03
Journal
Publisher
ISSN
Cited by
18
Access Type
Author Information
Authors
Elizabeth A. Stewart
Si Won Lee
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%